Starvation in the Treatment of Diabetic Ketoacidosis
1 other identifier
interventional
200
1 country
1
Brief Summary
Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are common, but serious metabolic disorders are often encountered in intensive care. In the intensive care setting, it is common to withhold food from patients during treatment of DKA. However, there is no evidence or current literature supporting this practice. The following proposed research investigates the initiation of an early diet versus withholding food during the treatment of diabetic ketoacidosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes-mellitus
Started Dec 2023
Typical duration for not_applicable diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2023
CompletedStudy Start
First participant enrolled
December 27, 2023
CompletedFirst Posted
Study publicly available on registry
December 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedAugust 19, 2025
August 1, 2025
1.8 years
November 14, 2023
August 18, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Resolution of DKA
Defined as a closed anion gap. Adjusted Anion Gap defined as (Blood Sodium - Blood Chloride - Blood Bicarbonate) + 0.25 x ((normal albumin (4.0)) x (observed albumin)); Elevated Anion Gap is \>12
Typically resolution of DKA is 24-72 hours, may be up to 5 days in some patients
Length of stay in the medical intensive care unit (in days).
The time from admission order is placed to the time the transfer to another unit order is placed
Days (Typically 3-5 days in the MICU, may be up to 1 week).
Secondary Outcomes (2)
Length of stay in the hospital
3-7 days, may be up to 1-2 weeks.
mortality
30 day
Study Arms (2)
Early feeding
EXPERIMENTALIf randomized to the experimental group, patient's diet will be advanced to clear liquid for the first day. On the second day, diet will be advanced to full liquid and advanced up to oral (carb controlled 1600 calories) diet as tolerated.
Nothing per mouth
NO INTERVENTIONPatient will be kept without PO intake until they are bridged from the insulin drip
Interventions
Participants in the treatment arm will be initiated on a clear liquid diet on day 1 of medical ICU admission. Diet will be progressed on day 2 to full liquid diet or diabetic diet as patient tolerates based on which diet the patient would prefer.
Eligibility Criteria
You may qualify if:
- Males and females with the diagnosis of diabetic ketoacidosis (defined as blood glucose greater than 250 mg/dL, arterial pH less than 7.3, serum bicarbonate less than 15 mEq/L, and the presence of ketonemia or ketonuria)
- Age between 18-89
- Admission to the Medical Intensive Care Unit
- Able to provide informed consent
You may not qualify if:
- Pregnant and breast-feeding women
- Institutionalized patients or prisoners
- Patients unable to eat by mouth, including intubation, presence of any tube used for enteral feeding (nasogastric tube, orogastric tube, PEG tube, etc.), medical conditions requiring parenteral feeding, and a history of a medical condition that prevented oral intake prior to admission, including achalasia, esophageal cancer, stroke with residual deficits preventing oral intake, amyotrophic lateral sclerosis, or head and neck trauma.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center
Lubbock, Texas, 79415, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kenneth Kenneth, MD
Texas Tech University Health Science Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2023
First Posted
December 29, 2023
Study Start
December 27, 2023
Primary Completion
November 1, 2025
Study Completion
December 1, 2025
Last Updated
August 19, 2025
Record last verified: 2025-08